Evidence map›Paper›PMID 27025960›Full record

ArticlePediatrics2016

Epidemiology of Acute Lower Respiratory Tract Infection in HIV-Exposed Uninfected Infants.

Cheryl Cohen, Jocelyn Moyes, Stefano Tempia, Michelle Groome, Sibongile Walaza, Marthi Pretorius, Fathima Naby, Omphile Mekgoe, Kathleen Kahn, Anne von Gottberg and 5 more

Open access · greenAbstract read
In one paragraph

Article in Pediatrics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 7 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 7 syntheses or guidelines pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Immunologic and Virologic Factors Associated With Hospitalization in Human Immunodeficiency Virus-Exposed, Uninfected Infants in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 6 countries.

Cheryl CohenCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, cherylc@nicd.ac.za.
Jocelyn MoyesCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences.
Stefano TempiaInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia; Influenza Programme and.
Michelle GroomeMedical Research Council, Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases.
Sibongile WalazaCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences.
Marthi PretoriusZoonosis Research Unit, Department of Medical Virology, University of Pretoria, Pretoria, South Africa;
Fathima NabyDepartments of Paediatrics, Pietermaritzburg Metropolitan Hospitals, University of KwaZulu-Natal, KwaZulu-Natal South Africa;
Omphile MekgoeDepartment of Paediatrics, Klerksdorp Hospital, Northwest Province, South Africa;
Kathleen KahnMRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, and Centre for Global Health Research, Umeå University, Umeå, Sweden; and INDEPTH Network, Accra, Ghana.
Anne von GottbergCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;
Nicole WolterCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;
Adam L CohenInfluenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia; Influenza Programme and.
Claire von MollendorfCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences.
Marietjie VenterZoonosis Research Unit, Department of Medical Virology, University of Pretoria, Pretoria, South Africa; Global Disease Detection, US Centers for Disease Control and Prevention-South Africa, Pretoria, South Africa;
Shabir A MadhiCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; Medical Research Council, Respiratory and Meningeal Pathogens Research Unit, Faculty of Health Sciences, Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases.
Faculty of Public Health · GBNational Health Laboratory Service · ZANational Influenza Center · MNUniversity of Pretoria · ZAUniversity of the Witwatersrand · ZAAgincourt Health and Socio-Demographic Surveillance System · ZAMedical Research Council · GBRespiratory and Meningeal Pathogens Research Unit · ZAUniversity of KwaZulu-Natal · ZA

Funding

Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09U01IP001048 · IP · NATIONAL HEALTH LABORATORY SERVICE · PI COHEN, CHERYL · 2016 to 2020
$19.9M
Intramural CDC HHS CC999999NCIRD CDC HHS U01 IP001048NCIRD CDC HHS U51 IP000155
6 · The paper itself

Abstract

backgroundIncreased morbidity and mortality from lower respiratory tract infection (LRTI) has been suggested in HIV-exposed uninfected (HEU) children; however, the contribution of respiratory viruses is unclear. We studied the epidemiology of LRTI hospitalization in HIV-unexposed uninfected (HUU) and HEU infants aged <6 months in South Africa.

methodsWe prospectively enrolled hospitalized infants with LRTI from 4 provinces from 2010 to 2013. Using polymerase chain reaction, nasopharyngeal aspirates were tested for 10 viruses and blood for pneumococcal DNA. Incidence for 2010-2011 was estimated at 1 site with population denominators.

resultsWe enrolled 3537 children aged <6 months. HIV infection and exposure status were determined for 2507 (71%), of whom 211 (8%) were HIV infected, 850 (34%) were HEU, and 1446 (58%) were HUU. The annual incidence of LRTI was elevated in HEU (incidence rate ratio [IRR] 1.4; 95% confidence interval [CI] 1.3-1.5) and HIV infected (IRR 3.8; 95% CI 3.3-4.5), compared with HUU infants. Relative incidence estimates were greater in HEU than HUU, for respiratory syncytial virus (RSV; IRR 1.4; 95% CI 1.3-1.6) and human metapneumovirus-associated (IRR 1.4; 95% CI 1.1-2.0) LRTI, with a similar trend observed for influenza (IRR 1.2; 95% CI 0.8-1.8). HEU infants overall, and those with RSV-associated LRTI had greater odds (odds ratio 2.1, 95% CI 1.1-3.8, and 12.2, 95% CI 1.7-infinity, respectively) of death than HUU.

conclusionsHEU infants were more likely to be hospitalized and to die in-hospital than HUU, including specifically due to RSV. This group should be considered a high-risk group for LRTI.

Indexed as

HIV InfectionsAcute DiseaseAnalysis of VarianceFemaleHospitalizationHospital MortalityHumansIncidenceInfantInfluenza, HumanMaleMetapneumovirusParamyxoviridae InfectionsProspective StudiesRespiratory Syncytial VirusesRespiratory Tract Infections

Identifiers

PMID27025960
PMCPMC9075335
OpenAlexW2315369446

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.